These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19859979)

  • 1. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase.
    Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A
    IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives.
    Freundlich JS; Yu M; Lucumi E; Kuo M; Tsai HC; Valderramos JC; Karagyozov L; Jacobs WR; Schiehser GA; Fidock DA; Jacobus DP; Sacchettini JC
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2163-9. PubMed ID: 16466916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Frecer V; Megnassan E; Miertus S
    Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives.
    Freundlich JS; Anderson JW; Sarantakis D; Shieh HM; Yu M; Valderramos JC; Lucumi E; Kuo M; Jacobs WR; Fidock DA; Schiehser GA; Jacobus DP; Sacchettini JC
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5247-52. PubMed ID: 16198563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli.
    Chhibber M; Kumar G; Parasuraman P; Ramya TN; Surolia N; Surolia A
    Bioorg Med Chem; 2006 Dec; 14(23):8086-98. PubMed ID: 16893651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzothiophene carboxamide derivatives as inhibitors of Plasmodium falciparum enoyl-ACP reductase.
    Banerjee T; Sharma SK; Kapoor N; Dwivedi V; Surolia N; Surolia A
    IUBMB Life; 2011 Dec; 63(12):1101-10. PubMed ID: 22006792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.
    Banerjee T; Sharma SK; Surolia N; Surolia A
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A
    J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition.
    Maity K; Bhargav SP; Sankaran B; Surolia N; Surolia A; Suguna K
    IUBMB Life; 2010 Jun; 62(6):467-76. PubMed ID: 20503440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum.
    Suguna K; Surolia A; Surolia N
    Biochem Biophys Res Commun; 2001 Apr; 283(1):224-8. PubMed ID: 11322792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
    Shah P; Siddiqi MI
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Kumar G; Banerjee T; Kapoor N; Surolia N; Surolia A
    IUBMB Life; 2010 Mar; 62(3):204-13. PubMed ID: 20131353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives.
    Kumar SP; George LB; Jasrai YT; Pandya HA
    SAR QSAR Environ Res; 2015; 26(1):61-77. PubMed ID: 25567142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors.
    Kapoor M; Dar MJ; Surolia A; Surolia N
    Biochem Biophys Res Commun; 2001 Dec; 289(4):832-7. PubMed ID: 11735121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of substrate binding loop mutations on the structure, kinetics, and inhibition of enoyl acyl carrier protein reductase from Plasmodium falciparum.
    Maity K; Banerjee T; Prabakaran N; Surolia N; Surolia A; Suguna K
    IUBMB Life; 2011 Jan; 63(1):30-41. PubMed ID: 21280175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.
    Nicola G; Smith CA; Lucumi E; Kuo MR; Karagyozov L; Fidock DA; Sacchettini JC; Abagyan R
    Biochem Biophys Res Commun; 2007 Jul; 358(3):686-91. PubMed ID: 17509532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenebissantin: a rare methylene-bridged bisflavonoid from Dodonaea viscosa which inhibits Plasmodium falciparum enoyl-ACP reductase.
    Muhammad A; Anis I; Ali Z; Awadelkarim S; Khan A; Khalid A; Shah MR; Galal M; Khan IA; Iqbal Choudhary M
    Bioorg Med Chem Lett; 2012 Jan; 22(1):610-2. PubMed ID: 22082562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
    Sharma SK; Parasuraman P; Kumar G; Surolia N; Surolia A
    J Med Chem; 2007 Feb; 50(4):765-75. PubMed ID: 17263522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.
    Surolia N; Surolia A
    Nat Med; 2001 Feb; 7(2):167-73. PubMed ID: 11175846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives.
    Kini SG; Bhat A; Pan Z; Dayan FE
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):730-6. PubMed ID: 20443682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.